These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

866 related items for PubMed ID: 10394183

  • 21. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR, Black S, Kuter BJ.
    J Infect Dis; 2008 Mar 01; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [Abstract] [Full Text] [Related]

  • 22. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
    Gohil DJ, Kothari ST, Chaudhari AB, Gunale BK, Kulkarni PS, Deshmukh RA, Chowdhary AS.
    Viral Immunol; 2016 Apr 01; 29(3):159-63. PubMed ID: 26910764
    [Abstract] [Full Text] [Related]

  • 23. [Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life].
    Desgrandchamps D, Schaad UB, Glaus J, Tusch G, Heininger U.
    Schweiz Med Wochenschr; 2000 Oct 14; 130(41):1479-86. PubMed ID: 11075412
    [Abstract] [Full Text] [Related]

  • 24. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, Douha M, Willems P.
    Vaccine; 2009 May 05; 27(20):2701-6. PubMed ID: 19428882
    [Abstract] [Full Text] [Related]

  • 25. [The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas].
    Oliveira J, Dias N, Ferreira TM, da Cunha S, Costa D, Côrte-Real R, Meliço-Silvestre A.
    Acta Med Port; 1999 May 05; 12(4-6):155-60. PubMed ID: 10481316
    [Abstract] [Full Text] [Related]

  • 26. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J, da Cunha S, Côrte-Real R, Sampaio L, Dais N, Meliço-Silvestre A.
    Acta Med Port; 1995 Apr 05; 8(4):206-16. PubMed ID: 7625214
    [Abstract] [Full Text] [Related]

  • 27. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
    Mossong J, Putz L, Schneider F.
    Epidemiol Infect; 2004 Jan 05; 132(1):11-8. PubMed ID: 14979584
    [Abstract] [Full Text] [Related]

  • 28. [Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults].
    Garrido Redondo M, Blanco Quirós A, Garrote Adrados JA, Tellería Orriols JJ, Arranz Sanz E.
    An Esp Pediatr; 1997 Nov 05; 47(5):499-504. PubMed ID: 9586291
    [Abstract] [Full Text] [Related]

  • 29. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A.
    Scand J Infect Dis; 2003 Nov 05; 35(10):736-42. PubMed ID: 14606613
    [Abstract] [Full Text] [Related]

  • 30. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
    Gupta M, Tripathy JP, Verma M, Singh MP, Kaur R, Ratho RK, Kumar R.
    Indian J Med Res; 2019 Mar 05; 149(3):396-403. PubMed ID: 31249206
    [Abstract] [Full Text] [Related]

  • 31. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul 05; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 32. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS, Brown ML, Xu J, Sullivan BJ, Marshall GS, Nauert B, Matson DO, Silas PE, Schödel F, Gress JO, Kuter BJ, Protocol 014 Study Group for ProQuad.
    Pediatrics; 2006 Feb 05; 117(2):265-72. PubMed ID: 16452343
    [Abstract] [Full Text] [Related]

  • 33. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry.
    Ramondetti F, Sacco S, Comelli M, Bruno G, Falorni A, Iannilli A, d'Annunzio G, Iafusco D, Songini M, Toni S, Cherubini V, Carle F, RIDI Study Group.
    Diabet Med; 2012 Jun 05; 29(6):761-6. PubMed ID: 22133003
    [Abstract] [Full Text] [Related]

  • 34. Seroprevalence of measles, rubella, and varicella in refugees.
    Barnett ED, Christiansen D, Figueira M.
    Clin Infect Dis; 2002 Aug 15; 35(4):403-8. PubMed ID: 12145723
    [Abstract] [Full Text] [Related]

  • 35. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
    Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M.
    J Infect Public Health; 2012 Apr 15; 5(2):127-32. PubMed ID: 22541258
    [Abstract] [Full Text] [Related]

  • 36. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P, Lim FS, Han HH, Willems P.
    Infection; 2007 Oct 15; 35(5):326-33. PubMed ID: 17710370
    [Abstract] [Full Text] [Related]

  • 37. Serosurveillance of varicella and hepatitis B infection after reported cases in medical students and the relationship between past varicella disease history and immunity status.
    Suwanpakdee D, Laohapand C, Moolasart V, Lomtong P, Krairojananan N, Srisawat P, Watanaveeradej V.
    J Med Assoc Thai; 2012 May 15; 95 Suppl 5():S80-5. PubMed ID: 22934450
    [Abstract] [Full Text] [Related]

  • 38. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA, Barakat SS, Abd El Fattah MM, Said ZN, El Metwally HA.
    East Mediterr Health J; 2009 May 15; 15(1):85-93. PubMed ID: 19469430
    [Abstract] [Full Text] [Related]

  • 39. [Seroprevalence of measles, rubella, mumps and varicella in health workers in the Community of Madrid].
    Rodríguez ML, Martínez D, Santos-Sancho JM, Borda JR, Orero A.
    Rev Esp Quimioter; 2014 Jun 15; 27(2):98-101. PubMed ID: 24940889
    [Abstract] [Full Text] [Related]

  • 40. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM.
    Ann Rheum Dis; 2012 Jun 15; 71(6):948-54. PubMed ID: 22172491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.